8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2008 / Intervention study
Seventeen healthy overweight and obese individuals followed a 3-month reduced-calorie diet with a 25% reduction in energy intake, comprising 55% carbohydrates, 20% proteins, and 25% fat, with no refined sugar. After 3 months, participants experienced significant decreases in BMI, waist circumference, body fat percentage, fasting glucose, post-OGTT glucose, glucose AUC, and HOMA2-IR. Serum BDNF significantly increased from 3.97 +/- 0.87 to 6.75 +/- 1.62 ng/ml (P = 0.02). Final serum BDNF correlated negatively with weight (r = -0.51, P = 0.03) and positively with basal post-OGTT insulin (r = 0.48, P = 0.04).
Araya AV, Orellana X, Espinoza J Endocrine, 2008. PMID 19012000
2008 / Randomized controlled trial
Thirty patients with schizophrenia were randomly allocated to a 10-week aerobic exercise routine performed three days weekly (n = 15) or a control group (n = 15). Relative to controls, participants in the exercise group had significant decreases in positive and negative symptom ratings as well as Brief Symptom Inventory scores. Scores on a standardized quality-of-life assessment also improved after completing the exercise program.
Acil AA, Dogan S, Dogan O J Psychiatr Ment Health Nurs, 2008. PMID 19012672
2008 / Randomized, double-blind, placebo-controlled clinical trial
A randomized, double-blind, placebo-controlled trial evaluated whether 120 mg of Ginkgo biloba extract twice daily reduced incident dementia compared to placebo over a median follow-up of 6.1 years. Overall, 523 participants developed dementia (277 in the G. biloba group and 246 in the placebo group). The hazard ratio for G. biloba compared with placebo was 1.12 (95% CI, 0.94-1.33; P = .21) for all-cause dementia and 1.16 (95% CI, 0.97-1.39; P = .11) for Alzheimer disease. G. biloba also did not alter progression to dementia in participants with mild cognitive impairment (HR, 1.13; 95% CI, 0.85-1.50; P = .39).
DeKosky ST, Williamson JD, Fitzpatrick AL, et al. JAMA, 2008. PMID 19017911
2007 / Randomized controlled trial
Researchers randomized 119 overweight community volunteers to either a low-carbohydrate, ketogenic diet (LCKD) or a low-fat diet (LFD) to evaluate mood, hunger, and other symptoms using the Atkins Health Indicator Test across 12 visits. After adjusting for BMI changes, participants experienced significant improvements in most symptoms on either diet. Significant diet group by visit interactions were found for negative affect [F(9,803) = 2.30, p = 0.015] and hunger [F(9,803) = 3.62, p < 0.0002], with participants in the LCKD group reporting less negative affect and hunger compared to the LFD group.
McClernon FJ, Yancy WS, Eberstein JA, et al. Obesity (Silver Spring), 2007. PMID 17228046
2007 / Randomized controlled trial follow-up
A follow-up study evaluated 52 of 79 healthy term infants previously enrolled in a randomized trial testing formula with DHA and ARA, alongside 32 breastfed children. At four years of age, visual acuity in control formula recipients was poorer than breastfed peers, whereas DHA and DHA plus ARA cohorts did not differ significantly from breastfed children. Verbal IQ was lower than breastfed children in the control and DHA-only groups.
Birch EE, Garfield S, Castañeda Y, et al. Early Hum Dev, 2007. PMID 17240089
2007 / Randomized controlled trial
The Women's Health Initiative trial randomized 36,282 postmenopausal women to receive calcium carbonate 500 mg with vitamin D 200 IU twice daily or placebo for 7 years, evaluating cardiovascular disease as a prespecified secondary outcome. Myocardial infarction or coronary heart disease death occurred in 499 women on calcium/vitamin D and 475 on placebo (HR 1.04; 95% CI 0.92 to 1.18). Stroke was confirmed in 362 women in the calcium/vitamin D group and 377 in the placebo group (HR 0.95; 95% CI 0.82 to 1.10).
Hsia J, Heiss G, Ren H, et al. Circulation, 2007. PMID 17309935
2007 / Randomized single-blind crossover trial
Ten healthy young adults were randomly and single-blind exposed for 30 minutes to mobile phone talk, listen, standby, or sham modes before a 90-minute sleep opportunity. There was no condition effect on subjective ratings of sleepiness. Post-exposure, sleep latency after talk mode was markedly and significantly delayed beyond listen and sham modes, an effect also evident in 1-4Hz frontal EEG power.
Hung CS, Anderson C, Horne JA, et al. Neurosci Lett, 2007. PMID 17548154
2007 / Randomized crossover trial
A double-blind randomized crossover trial examined drinks with sodium benzoate and artificial food color mixes (A or B) or placebo in 153 3-year-olds and 144 8/9-year-olds. Mix A significantly increased global hyperactivity aggregate scores in 3-year-olds compared to placebo (effect size 0.20; 95% CI 0.01-0.39; p = 0.044). In 8/9-year-olds with high protocol adherence, adverse effects occurred with mix A (0.12; 95% CI 0.02-0.23; p = 0.023) and mix B (0.17; 95% CI 0.07-0.28; p = 0.001).
McCann D, Barrett A, Cooper A, et al. Lancet, 2007. PMID 17825405
2007 / Randomized controlled trial
Cognitive testing was added near the close of the beta carotene arm (50 mg, alternate days) of the Physicians' Health Study II to assess general cognition, verbal memory, and category fluency in 5,956 men aged >65 years. Among 1,904 new recruits with a mean treatment duration of 1 year, cognition was similar between beta carotene and placebo groups. Among 4,052 continuing participants with a mean treatment duration of 18 years, the beta carotene group had a significantly higher mean global score (mean difference in z scores, 0.047; P = .03) and verbal memory score (mean difference in z scores, 0.063; P = .007) compared with placebo.
Grodstein F, Kang JH, Glynn RJ, et al. Arch Intern Med, 2007. PMID 17998490
2007 / Double-blind, placebo-controlled crossover trial
In a double-blind, placebo-controlled crossover pilot study, 7 participants with social phobia received either protein-source tryptophan (deoiled gourd seed) combined with carbohydrate or carbohydrate alone, with a 1-week washout between sessions. Protein-source tryptophan with carbohydrate resulted in significant improvement on an objective measure of anxiety, whereas carbohydrate alone did not. The authors conclude that protein-source tryptophan combined with high-glycemic carbohydrate is a potential anxiolytic for social phobia.
Hudson C, Hudson S, MacKenzie J Can J Physiol Pharmacol, 2007. PMID 18066139
2006 / Crossover experimental trial
Researchers measured cardiovascular and respiratory variables in 12 musicians and 12 age-matched controls while they listened to six music styles in random order with a randomly inserted two-minute pause. Faster tempi and simpler rhythmic structures increased ventilation, blood pressure, and heart rate, while decreasing mid-cerebral artery flow velocity and baroreflex compared with baseline. The pause reduced heart rate, blood pressure, and minute ventilation, even below baseline levels. Musicians demonstrated greater respiratory sensitivity to music tempo than non-musicians.
Bernardi L, Porta C, Sleight P Heart, 2006. PMID 16199412
2006 / Randomized controlled trial
In a randomized, double-blind trial, 602 schoolchildren aged 6 to 8 years received daily iron (30 mg), zinc (30 mg), both, or placebo for 6 months. Among the 527 participants completing treatment, testing evaluated 11 cognitive domains across memory, attention, learning, and visual-spatial abilities. Supplementation produced no consistent or durable differences in cognitive performance either immediately after treatment or after an additional 6 months of follow-up.
Rico JA, Kordas K, López P, et al. Pediatrics, 2006. PMID 16510631
2006 / Randomized crossover trial
A preliminary randomized, double-blind crossover trial examined the effects of a gluten-free and casein-free diet over 12 weeks in 15 children aged 2-16 years with autism spectrum disorder. Group-level analyses of autistic symptoms and urinary peptide concentrations revealed no statistically significant outcomes. While several parents reported behavioral improvements in their children, objective testing did not confirm diet efficacy.
Elder JH, Shankar M, Shuster J, et al. J Autism Dev Disord, 2006. PMID 16555138
2006 / Randomized controlled trial
Functional magnetic resonance imaging (fMRI) was used to measure blood oxygenation level-dependent (BOLD) responses to a cognitive task in 16 healthy young participants after consuming flavanol-rich cocoa (5 days of 150 mg cocoa flavanols). Ingestion of the flavanol-rich cocoa led to an increase in BOLD signal intensity during the task, though no significant effects were seen on behavioral reaction times, switch cost, or heart rate. Additionally, a pilot study demonstrated that a single acute dose of 450 mg flavanols increased cerebral blood flow to gray matter.
Francis ST, Head K, Morris PG, et al. J Cardiovasc Pharmacol, 2006. PMID 16794461
2006 / Experimental controlled trial
Fourteen normal subjects were exposed to a 60-minute nocturnal bright light pulse (1300 lx behind filters) while wearing orange lens blue blocker glasses or grey lens glasses. With the grey lenses, a significant 46% reduction in salivary melatonin was observed (95% CI, 35-57%; P < 0.05), whereas a non-significant increase of 6% occurred with the orange lenses (95% CI, -20% to 9%). The authors concluded that blue blockers represent an elegant means to prevent light-induced melatonin suppression, but further studies are needed to show that these glasses could facilitate adaptation to night work.
Sasseville A, Paquet N, Sévigny J, et al. J Pineal Res, 2006. PMID 16842544
2006 / Interventional PET imaging study
Eleven tobacco-dependent smokers participated in 14 2-FA PET scanning sessions during which they smoked 1 of 5 assigned amounts (none, 1 puff, 3 puffs, 1 full cigarette, or to satiety [2 1/2 to 3 cigarettes]). Smoking 0.13 (1 to 2 puffs) of a cigarette resulted in 50% occupancy of alpha 4 beta 2* nAChRs for 3.1 hours, and a venous plasma nicotine concentration of 0.87 ng/mL was associated with 50% occupancy. Smoking a full cigarette or more resulted in more than 88% receptor occupancy and was accompanied by a reduction in cigarette craving.
Brody AL, Mandelkern MA, London ED, et al. Arch Gen Psychiatry, 2006. PMID 16894067
2006 / Randomised double-blind placebo-controlled trial
A randomized, double-blind, placebo-controlled trial evaluated the effects of 0 (placebo), 15, or 30 mg/day of zinc supplementation over 3 and 6 months in 387 healthy adults aged 55-87 years. Younger adults (<70 years) outperformed older adults (>70 years) on all tests. For two out of eight dependent variables, significant interactions were observed: both 15 and 30 mg/day showed a beneficial effect at 3 months only on one measure of spatial working memory, whereas 15 mg/day showed a detrimental effect on one measure of attention. The authors note that further research is needed to determine whether findings apply to older adults in poorer health or with less adequate zinc status.
Maylor EA, Simpson EE, Secker DL, et al. Br J Nutr, 2006. PMID 17010236
2006 / Randomized controlled trial
Ninety consecutive patients with chronic tension-type headache were randomized to receive acupuncture, relaxation training, or physical training. Headache intensity, headache-free days, and headache-free periods were assessed via visual analogue scale and headache diary at 4 weeks before, immediately after, and at 3 and 6 months post-treatment. Immediately after treatment, the number of headache-free periods and days was significantly higher in the relaxation group compared with the acupuncture group. No other significant differences between groups were observed at any time point.
Söderberg E, Carlsson J, Stener-Victorin E Cephalalgia, 2006. PMID 17059439
2006 / Randomized, double-blind, placebo-controlled trial
In a substudy of the Women's Health Study, 6,377 women aged 65 or older were randomly assigned to receive 600 IU of vitamin E (alpha-tocopherol acetate) on alternate days or placebo. Cognitive assessments were conducted every 2 years by telephone over up to 9.6 years of treatment. No differences in global cognitive score were found between the vitamin E and placebo groups at the first assessment (mean difference, -0.01; 95% CI, -0.04 to 0.03) or at the final assessment (mean difference, 0.00; 95% CI, -0.04 to 0.04). Cognitive change over time was similar between groups (mean difference in change, 0.02; 95% CI, -0.01 to 0.05; P = .16), and the relative risk of substantial cognitive decline was 0.92 (95% CI, 0.77 to 1.10).
Kang JH, Cook N, Manson J, et al. Arch Intern Med, 2006. PMID 17159011
2005 / fMRI intervention study
Using fMRI, researchers measured hypothalamic neuronal activity in 15 normal-weight men after an overnight fast. Participants were scanned for 37 minutes and ingested either water or a glucose solution (25 or 75 g) after 7 minutes. Glucose ingestion produced a prolonged decrease in the hypothalamic fMRI signal that started shortly after drinking began and lasted at least 30 minutes. This response was dose-dependent, with a larger glucose load causing a larger signal decrease, which was most pronounced in the upper anterior hypothalamus.
Smeets PA, de Graaf C, Stafleu A, et al. Neuroimage, 2005. PMID 15627579
2005 / Randomized controlled trial
In a 6-week trial of 40 adults with mild to moderate depression, saffron extract (30 mg daily) was found to be similarly effective compared to fluoxetine (20 mg daily; F = 0.13, d.f. = 1, P = 0.71). No significant differences between groups were observed regarding side effects. The authors concluded that Crocus sativus is efficacious for depression, though larger trials remain necessary.
Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, et al. J Ethnopharmacol, 2005. PMID 15707766
2005 / Double-blind randomized controlled trial
In a double-blind trial, 769 subjects with amnestic mild cognitive impairment were randomly assigned to receive 2000 IU of vitamin E daily, 10 mg of donepezil daily, or placebo for three years. Over three years, possible or probable Alzheimer's disease developed in 212 subjects. Compared to placebo, there were no significant differences in progression to Alzheimer's disease in the vitamin E group (hazard ratio, 1.02; 95% CI, 0.74 to 1.41; P=0.91) or the donepezil group (hazard ratio, 0.80; 95% CI, 0.57 to 1.13; P=0.42). Donepezil reduced progression likelihood during the first 12 months (P=0.04), but vitamin E showed no benefit at any point, including among apolipoprotein E epsilon4 carriers.
Petersen RC, Thomas RG, Grundman M, et al. N Engl J Med, 2005. PMID 15829527
2005 / Randomized controlled trial
In a 6-month randomized trial, 602 first-grade Mexican children with lead exposure received daily 30 mg ferrous fumarate, 30 mg zinc oxide, both nutrients, or a placebo. Baseline blood lead averaged 11.5 mug/dL. The interventions did not show treatment effects on average score changes for parent- or teacher-assessed behaviors. However, children given zinc were more likely to resolve clinically significant oppositional ratings from teachers. Overall, the supplementation did not consistently improve behavior.
Kordas K, Stoltzfus RJ, López P, et al. J Pediatr, 2005. PMID 16291354
2005 / Double-blind randomized comparative trial
In a double-blind randomized comparative study, 27 preterm infants received formula with (n=16) or without (n=11) arachidonic acid (AA) and docosahexaenoic acid (DHA) for 6 months. Mean Mental Development Index scores for supplemented versus non-supplemented groups were 96.1 +/- 8.6 vs 91.7 +/- 10.4 at 6 months and 98.7 +/- 8.0 vs 90.5 +/- 6.9 at 1 year (p = 0.020). Mean Physical Development Index scores were 102.2 +/- 10.5 vs 95.4 +/- 13.2 at 6 months and 98.0 +/- 5.8 vs 86.7 +/- 11.1 at 1 year (p = 0.008). No differences were found in visual acuity, physical examination variables, or vital signs, and no obvious adverse effects occurred.
Fang PC, Kuo HK, Huang CB, et al. Chang Gung Med J, 2005. PMID 16382755